NIH-funded research R21 grant

How gut bacteria in HIV-exposed infants affect their growth and immunity

Official title: Influence of Early Life Gut Microbiota of HIV-Exposed Uninfected Infants on Inflammation, Growth and Immunity to Enteric Pathogens

Funded at Rutgers Biomedical and Health Sciences · NIH-10898915 · Data updated 2026-11-12

This study is looking at how the bacteria in the gut of infants who are exposed to HIV but not infected can affect their health, especially regarding inflammation and growth, to find ways to help these babies grow up healthier.

More Microbiota research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startAugust 3, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$243,050
NIH project number7R21AI179225-02
Project IDNIH-10898915 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants under 11 years old who are HIV-exposed but uninfected.

Less likely to help

Patients who are HIV-infected or older than 11 years may not benefit from this research.

What this research studies

This research investigates the impact of gut microbiota on the health of infants who are exposed to HIV but are not infected. It focuses on understanding how these infants experience increased inflammation and immune challenges, which may lead to growth issues like stunting. By analyzing the gut bacteria composition in these infants, the study aims to uncover potential links between gut health and immune responses to infections. The findings could help develop strategies to improve health outcomes for these vulnerable infants.

Why it matters

Potential benefit: If successful, this research could lead to improved health interventions for HIV-exposed infants, enhancing their growth and immune function.

How similar studies have gone: Previous studies have shown promising results regarding the role of gut microbiota in immune health, suggesting that this research could build on established findings.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Nyangahu, Donald — Rutgers Biomedical and Health Sciences
  • Study coordinator: Nyangahu, Donald

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.